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A B S T R A C T
Objectives: After a reasonable seizure-free period, discontinuation of antiepileptic drugs (AED) is usually
decided in epileptic patients despite the risk of seizure recurrence. In children, risk of recurrence after
discontinuation of AED is generally 20–40%; however, there is still no general agreement on the criteria to
predict safe discontinuation. This study was designed to determine the risk of recurrence and related risk
factors after drug withdrawal in epileptic children.
Methods: 200 epileptic patients between 1 month and 15 years of age who were followed at least 1 year
after drug withdrawal at a child neurology center between January 1993 and December 2005 formed the
study population of this retrospective study. Patients were classiﬁed into groups according to deﬁned risk
factors for recurrence.
Results: Of 200 patients (118 boys, 82 girls), overall recurrence rate was 27%. Girls were more likely to
have a seizure recurrence than boys, with the difference approaching statistical signiﬁcance (p = 0.058).
EEG recordings after withdrawal (post-withdrawal EEG) in the follow-up were signiﬁcantly different in
the patients with recurrencewith respect to presence of an abnormality (p = 0.05). In themultivariate Cox
regression analysis, female gender and abnormal post-withdrawal EEG were the risk factors inﬂuencing
seizure recurrence, with female gender identiﬁed as the main risk factor.
Conclusions: Although the decision to discontinue AED treatment necessitates evaluation of each patient
individually, our study suggests that female patients and those with abnormal EEG after withdrawal
require more cautious follow-up because of the high risk of recurrence.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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In patients with epilepsy, the critical question of discontinua-
tion of antiepileptic drugs (AED) arises after a seizure-free period.
Most childrenwill remain seizure-free after drugwithdrawal since
risk of recurrence after discontinuation of AED is generally 20–40%
in children.1–5 Age at onset of seizures, idiopathic etiology without
a neurological disease, absence of interictal abnormalities on ﬁrst
electroencephalogram (EEG) and EEG before withdrawal, duration
of AED withdrawal and seizure-free period before withdrawal are
associated with a low risk of recurrence; however, there is still no
general agreement with respect to the criteria to predict safe
discontinuation.1–7* Corresponding author. Tel.: +90 342 3606060; fax: +90 342 3603928.
E-mail addresses: aolmez@gantep.edu.tr, dr_akgun@yahoo.com (A. Olmez).
1 Present address: Gaziantep University, Faculty of Medicine, Department of
Pediatric Neurology, 27310 Gaziantep, Turkey.
Abbreviations: AED, antiepileptic drug; EEG, electroencephalogram; MRI, magnetic
resonance imaging.
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.10.011In view of the long-term adverse effects of AED together with
the psychosocial and economical burden of epilepsy, it is necessary
to determine the prognostic factors for drug withdrawal with
lower risk of recurrence.
This studywas designed to determine the risk of recurrence and
related risk factors after drug withdrawal in children with epilepsy
diagnosed and treated in a child neurology center during a long
time period.
2. Patients and methods
Epileptic patients whose AED were withdrawn and who were
followed at least 1 year after withdrawal between January 1993
and December 2005 in the outpatient clinic of the Department of
Pediatric Neurology, Hacettepe University, were included in the
study. Inclusion criteria were as follows: (1) Age at ﬁrst seizure
between 1 month and 15 years, (2) follow-up period of at least 1
year after the withdrawal, (3) seizures not due to neurometabolic
or infectious diseases of the central nervous system (CNS), and (4)
no history of seizures in the newborn period. Patients with avier Ltd. All rights reserved.
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criteria of epilepsy with regard to their clinical ictal symptoms and
epileptic discharges on EEG. A total of 200 patients (118 boys, 82
girls) were included in the study. After retrospective collection of
clinical and medical data from the hospital’s medical records,
patients were interviewed by telephone in December 2006 to
determine if seizures recurred in the long-term follow-up (133
patients). Patients were sent letters if they could not be reached by
telephone. Information in the medical records of the patients was
used for the analysis if they could not be reached by telephone or
letters (58 patients). Mean duration of follow-up in overall group
was 39.9  38.2 (0.25–172months).Maximumduration of follow-up
was 172 months (14 years and 4 months) after AED withdrawal. The
mean age at onset of ﬁrst seizure was 6.3  3.8 years (min: 0.1
months, max: 15 years).
Seizures were classiﬁed according to the 1989 classiﬁcation of
the International League Against Epilepsy (ILAE).8 Patients with
underlying signs and symptoms of brain injury, delayed psycho-
motor development, neurological abnormalities and abnormal
neuroimaging studies were deﬁned as having symptomatic
epilepsy; those with normal physical and neurological examina-
tion and normal neuroimaging studies were regarded as having
idiopathic epilepsy; and those not belonging to either idiopathic or
symptomatic epilepsy groupswere regarded as having cryptogenic
epilepsy. Mental retardation was generally estimated based on the
neurological examination and clinical estimation; however,
neuropsychological tests were also applied when mental retarda-
tion was suspected. Of the total, 18 patients had mental
retardation. Magnetic resonance imaging (MRI) studies were
available in 149 patients, 114 of which were normal. Abnormal
MRI consisted of asymmetrical ventricular dilatation, mesial
temporal lobe sclerosis, cortical dysplasias, periventricular leuko-
malacia, atrophies due to perinatal injury or cerebrovascular
events, cavernous angioma and hamartoma.
Twenty patients had no information regarding the ﬁrst EEG at
the time of the diagnosis and 38 patients had normal EEG;
diagnosis and determination of the type and classiﬁcation of
seizures were based primarily on the clinical data in these patients.
EEG recordings were considered abnormal if EEG included both
unequivocal epileptiform abnormalities and non-epileptiform
abnormalities such as paroxysmal slow waves and focal/general-
ized background irregularities. EEG tracings at the follow-up visits
1 year after the AED withdrawal period were accepted as ‘post-
withdrawal EEG’.
Of 200 patients, 92 (46%) had generalized, 75 (37.5%) had
partial, and 24 (12%) had mixed type of seizures; seizures in 9
(4.5%) patients could not be deﬁned from the available data. Fifty-
two patients (26%) had tonic, 51 (25.5%) had complex partial, 16
(8%) had simple partial, 15 (7.5%) had atonic, 12 (6%) had tonic-
clonic, 9 (4.5%) had absence, 8 (4%) had secondarily generalized,
and 3 (1.5%) had myoclonic seizures, and 1 patient (0.5%) had
epileptic spasms.
Fifty-eight of the patients (29%) were classiﬁed as having
idiopathic generalized epilepsy, 54 (27%) as idiopathic localiza-
tion-related epilepsy, 20 (10%) as symptomatic localization-
related epilepsy, 8 (4%) as symptomatic generalized epilepsy, 5
(2.5%) as cryptogenic generalized epilepsy, and 2 (1%) as
cryptogenic localization-related epilepsy. One patient (0.5%) was
diagnosed as reﬂex epilepsy (idiopathic hot water epilepsy with
simple partial and autonomic symptoms). Fifty-two patients could
not be classiﬁed because of inadequate clinical data and/or
neuroimaging studies or discrepancy between seizure type and
laboratory studies. Because of the relatively small number of
patients in the subgroups, seizure types were classiﬁed as
generalized, partial or mixed type of seizures and etiologicalepilepsy classiﬁcation was simpliﬁed as symptomatic-cryptogenic
(in the same group) or idiopathic epilepsy.
Epileptic syndromes could be deﬁned in only 38 patients. Of
these, 22 patients had benign childhood epilepsy with centro-
temporal spikes, 7 had juvenilemyoclonic epilepsy, 5 had temporal
lobe epilepsy (all symptomatic), 1 had cryptogenic childhood
epilepsy with occipital paroxysms, 2 had frontal lobe epilepsy
(without any apparent etiology), and 1 had Lennox–Gastaut
syndrome.
Regarding AED therapy before withdrawal, 156 patients (78%)
were treated by only 1 AED (66 by valproic acid, 57 by
carbamazepine, 29 by phenobarbital, 3 by phenytoin, 1 by
ethosuximide), 32 patients (16%) by 2 AED, 10 patients (5%) by
3 AED, 1 patient (0.5%) by 4 AED, and 1 patient (0.5%) by 5 AED. At
the time of withdrawal, only 4 patients were on combination
therapy with more than 1 AED. In these patients, the latest drug
was reduced ﬁrst and after its complete discontinuation, reduction
of the second drug was started, and so on until all drugs were
withdrawn. AED withdrawal was generally decided when patients
had at least a 2-year (mean: 40.3months) seizure-free period and a
normal EEG.1,2,8 All but 4 patients had EEG within 1 year before
withdrawal and 39 patients had abnormal EEG tracings, 10 of
which consisted of deﬁnite epileptiform abnormalities other than
minor epileptiform abnormalities like episodic slow waves or
background irregularities. Withdrawal of AED was performed
generally in 6 months. The average time of withdrawal was
6.6  0.1 months (min: 1 month, max: 14 months). Since this is a
retrospective study, patients with a seizure-free period of less than 2
years and withdrawal period shorter or longer than 6 months were
also included in the study.
Family history was accepted positive if ﬁrst-degree relatives
(parents and siblings) had a history of epilepsy or 1 or more
unprovoked seizures.
One patient had diagnosis of Bardet–Biedl syndrome, 1
tuberosclerosis and polycystic kidney disease, 1 scoliosis, 1 tic
disorder and 2 attention deﬁcit hyperactivity disorder in addition
to epilepsy.
The patients were classiﬁed in different groups to clarify the
risk factors according to sex, age at onset, family history of
epilepsy, history of previous febrile seizures, events in perinatal or
childhood history, neurological examination, mental retardation,
type of seizures, epilepsy classiﬁcation, MRI, time period between
the onset of ﬁrst seizure and start of AED treatment, time period
between the ﬁrst seizure and the last seizure (active disease), time
period between starting AED and last seizure (treatment response
time), time period between the last seizure and withdrawal of AED
treatment (seizure-free period), total duration of AED, duration of
withdrawal, number of seizures prior to starting the AED
treatment, number of seizures in the time period between the
start of AED treatment and the last seizure, ﬁrst EEG, and post-
withdrawal EEG.
2.1. Statistical analysis
SPSS statistical analysis software package version 11.5 (SPSS
Inc., Chicago, IL) was used in the statistical analysis. The chi-square
tests were used to determine the associations between categorical
data. Continuous variableswere examined usingMann–Whitney U
test. Associations and relative risks of variables and recurrence
during follow-up were investigated by Cox regression analysis.
Multivariate Cox regression was performed for factors that had
statistically signiﬁcant values up to 20% in univariate analysis.9
Statistical signiﬁcance was accepted at p < 0.05 and p values
between 0.05 and 0.10 were accepted as having a tendency for
signiﬁcance.
Table 1
Possible risk factors, clinical features and corresponding recurrence rate.
Subjects Recurrence rate % P values
No %
Sex
Male 118 59 22 0.058**
Female 82 41 34.1
Age at onset
<6 years 91 45.5 24.2 >0.05
6 years 109 54.5 29.4
Family history of epilepsy
Positive 29 14.5 27.6 >0.05
Negative 171 85.5 26.9
History of febrile seizures
Positive 40 20 20 >0.05
Negative 160 80 28.8
Perinatal/childhood history
Positive 63 31.5 20.6 >0.05
Negative 137 68.5 29.9
Neurological examination
Positive 19 9.5 31.6 >0.05
Negative 181 90.5 26.5
Mental retardation
Positive 18 9 38.9 >0.05
Negative 182 91 25.8
MRI
Abnormal 35 23.5 40 >0.05
Normal 114 76.5 28.1
Type of seizure
Generalized 92 48.2 28.3 >0.05
Partial 75 39.3 30.7
Mixed 24 12.6 20.8
Etiological epilepsy classiﬁcation
Idiopathic 112 76.2 31.3 >0.05
Symptomatic-cryptogenic 35 23.8 31.4
Time between the onset of ﬁrst seizure and the onset of AED treatment
0–2 months 101 50.5 31.7 >0.05
2–12 months 51 25.5 21.6
12 months 48 24 22.9
Active disease
0–6 months 95 47.5 29.5 >0.05
6–12 months 27 13.5 22.2
>12 months 78 39 25.6
Treatment response time
0–2 months 116 58 30.2 >0.05
2–12 months 36 18 19.4
12 months 48 24 25
Total duration of withdrawal
1–6 months 106 53 32.1 >0.05
>6 months 94 47 21.3
Total number of AED before remission
1 154 77 29.9 >0.05
2 32 16 18.8
3 14 7 14.3
Number of seizures before starting AED treatment
1–5 145 72.5 54.9 >0.05
6–10 9 4.5 22.2
>10 46 23 23.9
Number of seizures after AED treatment
No seizure 112 56 31.3 >0.05
1–5 43 21.5 37.2
6–10 10 5 10
>10 35 17.5 22.9
First EEG
Normal 38 21.1 31.6 >0.05
Abnormal 142 78.9 23.9
Table 1 (Continued )
Subjects Recurrence rate % P values
No %
Pre-withdrawal EEG
Normal 157 80.1 27.4 >0.05
Abnormal 39 19.9 23.1
Post-withdrawal EEG
Normal 124 79 16.1 0.05*
Abnormal 33 21 33.3
* Statistically signiﬁcant.
** Tendency for statistical signiﬁcance.
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Seizures recurred in 54 patients (27%). Twelve patients (6%) had
recurrence in the ﬁrst 3months after thewithdrawal, 16 (8%) in the
3–9 months period, 10 (5%) in the 9–15 months period, 2 (1%) in
the 15–24months period, and 14 (7%) had recurrence after 2 years.
The mean follow-up period after AED withdrawal was 47.7  39.3
months (min: 12 months, max: 172 months) in patients without
seizure recurrence and 18.6  24.9 months (min: 0.25 months, max:
126 months) in the patients with recurrence. The patient with the
longest lapse till recurrence after withdrawal had problems during
labor, the ﬁrst seizure occurred at the age of 1.5 months and
periventricular leukomalacia was present on MRI.
The general characteristics, clinical features and possible risk
factors of the patients are shown in Table 1.
Girls were determined more likely to have a seizure recurrence
than boys, and the difference approached statistical signiﬁcance
(p = 0.058).
With respect to post-withdrawal EEG recordings, patients with
recurrence more frequently had abnormal EEGs than those
without recurrence in the follow-up period after withdrawal,
and the difference was statistically signiﬁcant (p = 0.05, contin-
uous correction).
The seizure-free period was signiﬁcantly shorter in patients
with recurrence (median: 35 months; min: 7 months, max: 65
months) than in patients without recurrence (median: 36 months;
min: 12 months, max: 113 months) (p = 0.032).
Patients with seizure recurrence had a signiﬁcantly shorter
total duration of AED treatment (36.5 months; min: 12 months,
max: 210 months) than those without seizure recurrence (44.5
months; min: 7.5 months, max: 145 months) (p = 0.013).
With respect to post-withdrawal EEG recordings, patients with
recurrence more frequently had abnormal EEGs than those
without recurrence in the follow-up period after withdrawal,
and the difference was statistically signiﬁcant (p = 0.05, contin-
uous correction).
No other factors were statistically signiﬁcant.
Cox regression for univariate analysis was performed to
investigate the associations between the risk factors and clinical
outcome. Table 2 shows the possible risk factors demonstrating
statistical signiﬁcance or approaching signiﬁcance.
In the multivariate Cox regression analysis, female gender and
presence of abnormal post-withdrawal EEG were the risk factors
determined as having an inﬂuence on seizure recurrence (Table 3)
(Figs. 1 and 2). Female gender was determined as the main risk
factor for recurrence after AED withdrawal in our study.
4. Discussion
The recurrence rate after discontinuation of AED therapy was
27% in our study, which is consistent with other studies showing
Table 3
Relative risk (RR) of recurrence—multivariate Cox regression.
Variables RR 95% CI P value
Sex (female)** 2.88 1.34–6.18 p = 0.007*
EEG after withdrawal (abnormal) 2.38 1.13–5.02 p = 0.022*
Total time of AED treatment 0.99 0.97–1.03 p = 0.910
Seizure-free period 0.98 0.94–1.02 p = 0.269
* Statistically signiﬁcant.
** Main factor.
Fig. 2. Effect of post-withdrawal EEG abnormality on the probability that patients
will remain seizure-free after discontinuation of AED.
Table 2
Possible risk factors and relative risk (RR) of recurrence in univariate analysis.
Variables RR 95% CI P value
Sex (female) 1.93 1.12–3.30 p = 0.017
MRI (abnormal) 1.50 0.79–2.84 p = 0.21
First EEG (abnormal) 0.66 0.34–1.28 p = 0.22
Post-withdrawal EEG (abnormal) 2.09 0.99–4.36 p = 0.05
Total time of AED treatment 0.99 0.98–1 p = 0.13
Seizure-free period 0.98 0.96–0.99 p = 0.016
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after withdrawal of medication.1–7,10–12 The relapse rate was even
lower if patients with abnormal EEG before withdrawal, abnormal
neurological signs and epileptic syndromes known to have a poor
prognosis were excluded.1 Recurrences occurredmostly in the ﬁrst
2 years in our patients, as reported previously.1,2,11,12
Female gender was a signiﬁcant risk factor in univariate and
multivariate analyses in our study and was the main factor
inﬂuencing the recurrence rate in multivariate analysis; however,
we could not determine any reason for this gender differencewhen
all the risk factors were analyzed according to gender (data not
shown). Similar to our results, Altunbas¸ak et al.1 and Dooley et al.13
found that female gender was a signiﬁcant risk factor for relapse.
Gender has usually been reported to have no inﬂuence on the
relapse risk.2,4,5,11–14 This discrepancy may result from the
differences in the study populations and study designs in other
studies or because of our limitation in obtaining data about
neuroimaging studies or classiﬁcation of epilepsy syndromes in
some of the patients.
In recent years, therehas beenageneral acceptanceof at least a2-
year seizure-free period before AED withdrawal,1,2,4 althoughFig. 1. Effect of sex on the probability that patients will remain seizure-free after
discontinuation of AED.seizure-free periods shorter than 4 years have also been reported
asa risk factor for seizure recurrence inchildren.14–16 Inaprospective
randomized study, after earlywithdrawal of AED at 6 and 12months
of therapy, 49% versus 48% of children were seizure-free at 2 years,
respectively.17Whileearlywithdrawalmayprevent theunnecessary
sideeffectsofAEDtherapyandlower thestressofmedicationonboth
patients and families, it can increase the risk of recurrence. Although
the seizure-free period has not been found as a signiﬁcant risk factor
inmost of the studies, in a prospective studywith 433 patients, AED
were withdrawn after 2, 3, 4 seizure-free years and patients were
observed at least 3 years.14 The rate of relapse was strongly
associated with the duration of the seizure-free period and the risk
of relapse signiﬁcantly decreased only after a seizure-free period of
3 years without restriction of all types of seizure and at least 3 years
of seizure-freedom was suggested like some other studies.14,16
Our results also showed that a seizure-free period and total duration
of AED treatment of more than 3 years are important factors
inﬂuencing the recurrence rate, consistent with some studies.5,14,16
Results from the studies about age at onset of ﬁrst seizure are
controversial. Altunbas¸ak et al.1 found less than 2 years of age at
onset as a good prognostic factor in his study, in which epileptic
syndromes with bad prognosis were excluded, whereas Emerson
et al.18 found age at onset related with seizure recurrence. Age at
onset of more than 12 years was reported as a risk factor for
recurrence by Shinnar et al.5 and Peters et al.17 Bouma et al.2
reported a good prognosis for patients with no abnormal
neurological signs or mental retardation and with onset of seizure
at more than 5 years of age. On the other hand, some authors
reported results similar to ours, that age at onset had no inﬂuence
on seizure recurrence.12,14 We did not ﬁnd age at onset as a
signiﬁcant risk factor, perhaps due to the unselected group
comprising our patient population that included both benign
epilepsies and epilepsies known as having poor prognosis.
Family history of epilepsy was reported as a risk factor in
idiopathic epileptic patients by Shinnar et al.5, but it was not found
as a risk factor in our study, which is consistent with some of the
studies.1,2,19 History of febrile convulsions was also not found as a
risk factor in our study, and this also supports the results of other
studies.1,2,19
Abnormal neurological examination and mental retardation of
varying degree can be related to recurrence,2,5,7,13–15 but this was
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be attributed to the fact that only 2 patients in our study had a
moderate degree of mental retardation; the others had mild
mental retardation.
Gherpelli et al.12, Todt14 and Emerson et al.18 found the number
of seizures before seizure control important for seizure recurrence.
Duration of active disease (greater than 2 to 6 years before seizure
control) and time lapsed between the ﬁrst seizure and onset of AED
treatment have been reported as risk factors in a few stu-
dies.12,15,20,21 Polytherapy has been found as a risk factor in a
selected population with partial epilepsy.19 Factors related to
seizure severity prior to achieving full seizure control (seizure
frequency before AED treatment, seizure frequency while on AED
treatment until seizure control, time lapse between the onset of
ﬁrst seizure and the onset of AED treatment, treatment response
time [time elapsed from the onset of AED treatment to full seizure
control] and number of AED before full remission) were not
determined to be signiﬁcant for seizure recurrence in our study, as
reported in other studies.1,15,16
We found no difference between the groups of patients with
AED tapering period of more versus less than 6 months, like Serra
et al.3, who compared the tapering duration of 1-month to a 6-
month period. However, tapering duration of less than 6 months
has also been reported as a signiﬁcant risk factor.14 The lack of a
consensus in the literature may be related to limited data with
respect to these factors.
We did not ﬁnd any signiﬁcant difference according to seizure
types. Shinnar et al.5 reported no difference between the complex
partial and tonic-clonic seizures in the idiopathic and remote
symptomatic patient groups, but presence of absence seizures
increased the risk of seizure recurrence in the remote symptomatic
group. Todt14 found partial epilepsies andmixed type of seizures as
a risk factor, but Matricardi et al.15 reported that infantile spasms
and childhood absence epilepsy carried a greater risk of relapse
after AED withdrawal. In contrast, having only absence seizures
has been reported as a predictor of excellent prognosis.6 We think
the differences reported regarding the effect of seizure type can be
attributed to differences in the study designs and characteristics of
the studied populations.
Etiology of seizures has also been related to increased risk of
recurrence after AED withdrawal. The remote symptomatic
epilepsy group has been most signiﬁcantly related to higher
relapse rates when compared to the idiopathic group.5,14–17 No
difference was found in the other studies.1,2,13 In our study as well,
etiology, either symptomatic–cryptogenic or idiopathic, was not
identiﬁed as a possible risk factor.
Studies have reported conﬂicting results about the role of
epileptiform abnormalities on EEG in predicting the recurrence
rate. It has been found as both a prognostic factor5,10,12 and a non-
prognostic factor.1,2,16 We showed no effect on seizure recurrence
of the ﬁrst EEG at the time of diagnosis or of the EEG obtained
before the withdrawal. The conﬂicting results about EEG may be
due to deﬁnitions of abnormal EEG. Shinnar et al.5 found that only
slowing on the ﬁrst EEG, whether focal or generalized in the
idiopathic epilepsy group, had a higher risk of recurrence, while
signiﬁcant epileptiform EEG abnormalities were not associated
with a higher risk of recurrence. Altunbas¸ak et al.1 included
patients with normal EEG and with minor epileptiform abnorm-
alities like episodic slow waves and could not determine EEG to be
predictive for relapse. An abnormal EEG consisting of spikes, sharp
waves, polyspikes and spikes and slow waves in the year before
discontinuation of AED increased the relapse risk in other
studies.12,15,16 In addition, paroxysmal features appearing or
persisting in the course of the disease were reported as a good
predictor of relapse.15 Most of the studies have not considered EEGabnormalities afterwithdrawal of AED.We found the EEG obtained
after rather than before withdrawal of medication to be important
in predicting the recurrence rate in our study in both bivariate and
multivariate analyses. Similarly, Todt14 and Verrotti et al.19,22
determined the post-withdrawal EEG to be predictive of the
recurrence rate. EEG recordings after withdrawal can be suggested
in the follow-up period, although startingmedication based on EEG
abnormality is questionable. Nevertheless, it can help in accurate
counselling of the patient and the family regarding prognosis.
5. Conclusion
In our study, overall recurrence rate was 27% in children, and
most occurred during the ﬁrst 2 years. The main factor for
predicting risk of recurrence was female gender. EEG obtained
after withdrawal was the other factor important for predicting risk
of recurrence. Total duration of AED treatment and the seizure-free
period were important risk factors. Based on the results of our
study, we suggest a seizure-free period of at least 3 years on AED
medication, close follow-up of female patients, and being cautious
about the abnormalities on EEG recordings obtained during follow-
up after withdrawal of AED treatment regarding prognosis.
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